Envestnet Asset Management Inc Seres Therapeutics, Inc. Transaction History
Envestnet Asset Management Inc
- $281 Billion
- Q2 2024
Shares
3 transactions
Others Institutions Holding MCRB
# of Institutions
96Shares Held
46.3MCall Options Held
119KPut Options Held
466K-
Flagship Pioneering Inc. Cambridge, MA23.1MShares$21.3 Million1.99% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.29MShares$5.78 Million0.0% of portfolio
-
Tang Capital Management LLC San Diego, CA2.41MShares$2.21 Million0.21% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.78MShares$1.64 Million0.0% of portfolio
-
Black Rock Inc. New York, NY1.76MShares$1.62 Million0.0% of portfolio
About Seres Therapeutics, Inc.
- Ticker MCRB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 124,072,000
- Market Cap $114M
- Description
- Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company's lead product candidate is the SER-109, an oral microbiome therapeutic candidate that has completed Phase III clinical trial for the ...